PolyPid Current Deferred Revenue vs Total Assets Analysis
| PYPD Stock | USD 4.32 0.12 2.70% |
PolyPid financial indicator trend analysis is much more than just breaking down PolyPid prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PolyPid is a good investment. Please check the relationship between PolyPid Current Deferred Revenue and its Total Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.
Current Deferred Revenue vs Total Assets
Current Deferred Revenue vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PolyPid Current Deferred Revenue account and Total Assets. At this time, the significance of the direction appears to have no relationship.
The correlation between PolyPid's Current Deferred Revenue and Total Assets is 0.08. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Total Assets in the same time period over historical financial statements of PolyPid, assuming nothing else is changed. The correlation between historical values of PolyPid's Current Deferred Revenue and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of PolyPid are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Current Deferred Revenue i.e., PolyPid's Current Deferred Revenue and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.08 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Total Assets
Total assets refers to the total amount of PolyPid assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in PolyPid books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from PolyPid's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PolyPid current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.At present, PolyPid's Enterprise Value is projected to decrease significantly based on the last few years of reporting.
PolyPid fundamental ratios Correlations
Click cells to compare fundamentals
PolyPid Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PolyPid fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 33.8M | 75.8M | 44.2M | 26.0M | 15.4M | 25.8M | |
| Other Current Liab | 998K | 1.7M | 3.4M | (31K) | 2.0M | 1.4M | |
| Total Current Liabilities | 2.6M | 2.9M | 7.8M | 8.6M | 7.3M | 4.0M | |
| Total Stockholder Equity | 30.9M | 72.8M | 36.2M | 5.9M | (2.1M) | (2.2M) | |
| Property Plant And Equipment Net | 6.1M | 5.9M | 8.8M | 11.7M | 9.2M | 5.3M | |
| Net Debt | (3.9M) | (4.3M) | (9.8M) | 5.2M | 6.2M | 6.5M | |
| Retained Earnings | (93.3M) | (132.3M) | (174.6M) | (214.4M) | (238.3M) | (226.4M) | |
| Accounts Payable | 1.6M | 974K | 4.1M | 1.1M | 772K | 1.3M | |
| Cash | 3.9M | 4.3M | 9.8M | 8.6M | 5.6M | 5.8M | |
| Non Current Assets Total | 6.4M | 28.3M | 9.4M | 11.8M | 9.3M | 7.8M | |
| Non Currrent Assets Other | 31K | 22.2M | 423K | 99K | 87K | 82.7K | |
| Other Assets | 230K | 22.8M | 663K | 99K | 113.9K | 108.2K | |
| Cash And Short Term Investments | 26.6M | 44.5M | 32.2M | 12.6M | 5.6M | 5.3M | |
| Net Receivables | 42K | 139K | 118K | 298K | 342.7K | 359.8K | |
| Common Stock Shares Outstanding | 13.3M | 319.4K | 624.1K | 647.6K | 1.4M | 1.8M | |
| Liabilities And Stockholders Equity | 33.8M | 75.8M | 44.2M | 26.0M | 15.4M | 25.8M | |
| Non Current Liabilities Total | 251K | 193K | 199K | 11.5M | 10.2M | 9.7M | |
| Other Current Assets | 399K | 2.3M | 25.0M | 1.1M | 458K | 435.1K | |
| Other Stockholder Equity | 124.2M | 205.1M | 210.8M | 220.3M | 236.2M | 248.0M | |
| Total Liab | 2.8M | 3.1M | 8.0M | 20.1M | 17.5M | 24.1M | |
| Total Current Assets | 27.4M | 47.6M | 34.8M | 14.2M | 6.1M | 5.8M | |
| Accumulated Other Comprehensive Income | (766K) | (1.2M) | (106.4M) | (3.1M) | (2.8M) | (3.0M) | |
| Property Plant Equipment | 6.1M | 5.9M | 8.8M | 11.7M | 13.4M | 14.1M | |
| Other Liab | 251K | 193K | 199K | 2.8M | 3.3M | 3.4M | |
| Net Tangible Assets | (87.6M) | 72.8M | 36.2M | 5.8M | 6.7M | 7.0M | |
| Short Term Investments | 14.0M | 0.0 | 22.7M | 40.2M | 22.4M | 4.0M | |
| Non Current Liabilities Other | 251K | 193K | 199K | 174K | 398K | 273.2K | |
| Net Invested Capital | 30.9M | 72.8M | 36.2M | 17.5M | 8.3M | 8.7M | |
| Net Working Capital | 24.8M | 44.3M | 27.0M | 5.6M | (1.2M) | (1.2M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for PolyPid Stock analysis
When running PolyPid's price analysis, check to measure PolyPid's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyPid is operating at the current time. Most of PolyPid's value examination focuses on studying past and present price action to predict the probability of PolyPid's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyPid's price. Additionally, you may evaluate how the addition of PolyPid to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Is PolyPid's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.99) | Return On Assets (0.69) | Return On Equity (12.79) |
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.